Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 5
2019 5
2020 10
2021 7
2022 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
In Silico Models for Developmental Toxicity.
Marzo M, Roncaglioni A, Kulkarni S, Barton-Maclaren TS, Benfenati E. Marzo M, et al. Methods Mol Biol. 2022;2425:217-240. doi: 10.1007/978-1-0716-1960-5_10. Methods Mol Biol. 2022. PMID: 35188635
Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma.
Ghirardelli P, Franceschini D, D'Aveni A, Dominici L, Ravasio A, Marzo M, Villa E, Di Noia V, Scorsetti M, Vavassori V, Ceresoli GL. Ghirardelli P, et al. Among authors: marzo m. Lung Cancer. 2021 Feb;152:1-6. doi: 10.1016/j.lungcan.2020.11.022. Epub 2020 Nov 26. Lung Cancer. 2021. PMID: 33310300
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection.
Franzese C, Perrino M, Marzo MA, Badalamenti M, Baldaccini D, D'Agostino G, Marini B, De Vincenzo F, Zucali PA, Scorsetti M. Franzese C, et al. Among authors: marzo ma. Clin Exp Metastasis. 2022 Jun;39(3):449-457. doi: 10.1007/s10585-022-10158-7. Epub 2022 Feb 21. Clin Exp Metastasis. 2022. PMID: 35190933
Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy.
Loi M, Franceschini D, Dominici L, Chiola I, Franzese C, D'Agostino GR, Navarria P, Marzo M, Paganini L, Comito T, Mancosu P, Tomatis S, Cozzi L, Alifano M, Scorsetti M. Loi M, et al. Among authors: marzo m. Strahlenther Onkol. 2021 May;197(5):396-404. doi: 10.1007/s00066-020-01687-9. Epub 2020 Sep 24. Strahlenther Onkol. 2021. PMID: 32970163
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
Franceschini D, Comito T, Di Gallo A, Vernier V, Marzo MA, Di Cristina L, Marini B, Lo Faro L, Stefanini S, Spoto R, Dominici L, Franzese C, Scorsetti M. Franceschini D, et al. Among authors: marzo ma. Curr Oncol. 2022 Oct 17;29(10):7858-7867. doi: 10.3390/curroncol29100621. Curr Oncol. 2022. PMID: 36290898 Free PMC article. Clinical Trial.
28 results